In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.

Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
At present, the market is developing rapidly and the key players include Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, etc.
North America is the largest consumption place, with a revenue market share nearly 42.6% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 30.2%. China is the region with high growth potential; from 2012 to 2016 the CAGR of China is around 15%.
The global Veterinary Products for Companion Animals market is valued at 13500 million US$ in 2017 and will reach 20700 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2018-2025.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Type I
- Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
- Dogs
- Cats
- Other

The study objectives of this report are:
- To analyze and study the global Veterinary Products for Companion Animals sales, value, status (2013-2017) and forecast (2018-2025);
- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
- Focuses on the key Veterinary Products for Companion Animals players, to study the sales, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Veterinary Products for Companion Animals are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Veterinary Products for Companion Animals market, by end-use.
Detailed analysis and profiles of additional market players.

Related Reports

Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and well share relevant market report titles for you to explore.

BFS (Blow-Fill-Seal) technology is a manufacturing technique used to produce small, (0.1mL) and large volume, (500mL +) liquid-filled containers. Originally developed in Europe in the 1930s, it was introduced in the United States in the 1960s, but over the last 20 years it has become more prevalent ...

BFS (Blow-Fill-Seal) technology is a manufacturing technique used to produce small, (0.1mL) and large volume, (500mL +) liquid-filled containers. Originally developed in Europe in the 1930s, it was introduced in the United States in the 1960s, but over the last 20 years it has become more prevalent ...

Glucosamine is primarily derived from shellfish, which is an amino sugar that is essential for the biosynthesis of glycosylated proteins and lipids. Glucosamine has been showed to help rebuild and repair human cartilage, and is used as a base ingredient in joint health dietary supplements. It is oft...

Glucosamine is primarily derived from shellfish, which is an amino sugar that is essential for the biosynthesis of glycosylated proteins and lipids. Glucosamine has been showed to help rebuild and repair human cartilage, and is used as a base ingredient in joint health dietary supplements. It is oft...

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue...

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue...

Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate te...

Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate te...

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Scope of the Report:
This report focuses o...

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Scope of the Report:
This report focuses o...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.

Top Fortune 500 Organizations trust us for research data.

24/7 support on call as well as emails.

Your Details are safe with us.

Free support for your research requirements.

Report Delivery: Email

Delivery Time:

Upto 24 hrs - working days

Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.